SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma

Biochemistry, Genetics and Molecular Biology

• Interleukin-6 100%
• Interleukin-1 100%
• Ubiquitination 100%
• Cytokine 100%
• Tumor Necrosis Factor 100%
• Cancer Cell 50%
• Proinflammatory Cytokine 50%
• Molecular Weight 50%
• Bcl-2 50%
• Retrospective Study 50%
• Bcl-xL 50%
• Cytochrome 50%
• Cell Viability 50%
• Gene Knockdown 50%
• Gene Overexpression 50%
• Carcinogenesis 50%
• Caspase 3 50%
• Caspase-9 50%